These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 9108934)

  • 1. Leukemogenesis by Moloney murine leukemia virus: a multistep process.
    Fan H
    Trends Microbiol; 1997 Feb; 5(2):74-82. PubMed ID: 9108934
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A multistep process of leukemogenesis in Moloney murine leukemia virus-infected mice that is modulated by retroviral pseudotyping and interference.
    Lavignon M; Evans L
    J Virol; 1996 Jun; 70(6):3852-62. PubMed ID: 8648721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An enhancer variant of Moloney murine leukemia virus defective in leukemogenesis does not generate detectable mink cell focus-inducing virus in vivo.
    Brightman BK; Rein A; Trepp DJ; Fan H
    Proc Natl Acad Sci U S A; 1991 Mar; 88(6):2264-8. PubMed ID: 2006167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential behavior of the Mo + PyF101 enhancer variant of Moloney murine leukemia virus in rats and mice.
    Brightman BK; Okimoto M; Kulkarni V; Lander JK; Fan H
    Virology; 1998 Mar; 242(1):60-7. PubMed ID: 9501051
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant mink cell focus-inducing virus and long terminal repeat alterations accompany the increased leukemogenicity of the Mo+PyF101 variant of Moloney murine leukemia virus after intraperitoneal inoculation.
    Belli B; Patel A; Fan H
    J Virol; 1995 Feb; 69(2):1037-43. PubMed ID: 7815481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Susceptibility and resistance to Moloney murine leukemia virus-induced promonocytic leukemia.
    Nazarov V; Hilbert D; Wolff L
    Virology; 1994 Dec; 205(2):479-85. PubMed ID: 7975249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early (preleukemic) events in Moloney murine leukemia virus leukemogenesis.
    Fan H; Brightman BK; Belli B; Okimoto M; Tao M
    Leukemia; 1997 Apr; 11 Suppl 3():149-51. PubMed ID: 9209326
    [No Abstract]   [Full Text] [Related]  

  • 8. Radiation leukemia virus-induced leukemogenesis: a paradigm of preleukemia and its control by preventive therapy.
    Yefenof E; Kotler M
    Adv Cancer Res; 1995; 66():293-312. PubMed ID: 7793318
    [No Abstract]   [Full Text] [Related]  

  • 9. Characterization of a preleukemic state induced by Moloney murine leukemia virus: evidence for two infection events during leukemogenesis.
    Davis BR; Brightman BK; Chandy KG; Fan H
    Proc Natl Acad Sci U S A; 1987 Jul; 84(14):4875-9. PubMed ID: 3474632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Escape from in vivo restriction of Moloney mink cell focus-inducing viruses driven by the Mo+PyF101 long terminal repeat (LTR) by LTR alterations.
    Brightman BK; Farmer C; Fan H
    J Virol; 1993 Dec; 67(12):7140-8. PubMed ID: 8230436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Appearance of mink cell focus-inducing recombinants during in vivo infection by moloney murine leukemia virus (M-MuLV) or the Mo+PyF101 M-MuLV enhancer variant: implications for sites of generation and roles in leukemogenesis.
    Lander JK; Chesebro B; Fan H
    J Virol; 1999 Jul; 73(7):5671-80. PubMed ID: 10364317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of the LTR region between the enhancer and promoter in mink cell focus-forming murine leukemia virus pathogenesis.
    Yoshimura FK; Wang T
    Virology; 2001 Apr; 283(1):121-31. PubMed ID: 11312668
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sequences responsible for erythroid and lymphoid leukemia in the long terminal repeats of Friend-mink cell focus-forming and Moloney murine leukemia viruses.
    Ishimoto A; Takimoto M; Adachi A; Kakuyama M; Kato S; Kakimi K; Fukuoka K; Ogiu T; Matsuyama M
    J Virol; 1987 Jun; 61(6):1861-6. PubMed ID: 3033317
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The leukemogenic potential of an enhancer variant of Moloney murine leukemia virus varies with the route of inoculation.
    Belli B; Fan H
    J Virol; 1994 Nov; 68(11):6883-9. PubMed ID: 7933068
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leukaemogenesis by the delta Mo + SV Moloney murine leukaemia virus (M-MuLV) variant in E mu pim-1 transgenic mice: high frequency of recombination with a solo endogenous M-MuLV LTR in vivo.
    Suchman EL; Pattengale PK; Fan H
    J Gen Virol; 1995 Feb; 76 ( Pt 2)():347-56. PubMed ID: 7844555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gross murine leukemia virus-induced alterations in the thymus of preleukemic AKR mice.
    Beardsley TR; Hays EF
    Cancer Res; 1979 Feb; 39(2 Pt 1):480-6. PubMed ID: 32967
    [No Abstract]   [Full Text] [Related]  

  • 17. Moloney murine leukemia virus-induced preleukemic thymic atrophy and enhanced thymocyte apoptosis correlate with disease pathogenicity.
    Bonzon C; Fan H
    J Virol; 1999 Mar; 73(3):2434-41. PubMed ID: 9971828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Involvement of the spleen in preleukemic development of a murine retrovirus-induced promonocytic leukemia.
    Nason-Burchenal K; Wolff L
    Cancer Res; 1992 Oct; 52(19):5317-22. PubMed ID: 1394137
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined infection by Moloney murine leukemia virus and a mink cell focus-forming virus recombinant induces cytopathic effects in fibroblasts or in long-term bone marrow cultures from preleukemic mice.
    Li QX; Fan H
    J Virol; 1990 Aug; 64(8):3701-11. PubMed ID: 2164592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retroviral gene insertion in breast milk mediated lymphomagenesis.
    Chakraborty J; Okonta H; Bagalb H; Lee SJ; Fink B; Changanamkandat R; Duggan J
    Virology; 2008 Jul; 377(1):100-9. PubMed ID: 18501945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.